AFIB ALERT: Klein Law Firm Announces Deadline for Lead Plaintiff of April 18, 2022 in Class Action Lawsuit Filed on Behalf of Shareholders of Acutus Medical, Inc.

NEW YORK, March 29, 2022 /PRNewswire/ — Klein Law Firm Announces Class Action Lawsuit Has Been Filed on Behalf of Acutus Medical, Inc. (NASDAQ: AFIB) Shareholders Alleging the Company Violated Federal Securities Laws movables.

This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021included.
Lead Applicant Deadline: April 18, 2022
No obligation or cost to you.

Learn more about your recoverable losses in AFIB:

Acutus Medical, Inc. NEWS – AFIB NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Acutus Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) a significant percentage of the company’s current AcQMap imaging and mapping systems were randomly installed at sites with little, if any, consideration of the likelihood that healthcare providers at the selected sites would adopt or desire the Company’s products; (b) a significant percentage of the AcQMap systems being evaluated had been installed in locations where the Company did not have the necessary infrastructure to appropriately educate, train and support medical service providers on system operations; (c) as a result of (a) and (b) above, Defendants were in the process of devising a strategic plan to terminate and displace approximately 20% of the then-existing AcQMap Systems Assessment Agreements; (d) the Company’s management’s discussion and analysis was materially false and misleading and did not disclose that the termination and relocation of approximately 20% of existing AcQMap Systems Assessment Agreements was reasonably likely to occur. have a material adverse effect on the financial results of the Company in 2021; and (e) discussions of the Company’s risk factors were materially false and misleading and referred to potential risks without disclosing that such risks then existed or adequately describing the specific nature of the risks then facing the Company.

WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you suffered a claim in Acutus, you have until April 18, 2022 ask the court to obtain the status of principal plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.

AT NO CHARGE TO YOU: If you purchased Acutus securities during the relevant period, you may be entitled to compensation without payment of out-of-pocket costs.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For more information on the AFIB lawsuit, please contact J. Klein, Esq. by phone at 212-616-4899 or click on this link:

J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Klein Law Firm is a litigation firm with experience in a wide range of areas, including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertisement. Prior results do not guarantee similar results.

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899

View original content: – the-class-action-filed-on-behalf-of-the-shareholders-of-acutus-medical-inc-301512003.html

SOURCE Klein Law Firm